Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
AZD7762
Cat No.
CEI-0293
Description
AZD7762 inhibit CHK1 and CHK2 with IC50 of 5 nM and 10 nM.
CAS No.
860352-01-8
Molecular Weight
362.42
Purity
>99%
Storage
2 years at -20centigrade Powder
Targets
CHK1, CHK2
Molecular Formula
C17H19FN4O2S
Chemical Name
1-(2-((S)-piperidin-3-ylcarbamoyl)-5-(3-fluorophenyl)thiophen-3-yl)urea
Solubility
DMSO 50 mg/mL Water
In vitro
AZD7762 is a inhibitor of checkpoint kinase 1 (Chk1), which functions as a regulatory kinase in cell cycle progression and is a critical effector of the DNA-damage response. As a ATP competitive inhibitor, AZD7762 binds in the ATP-binding site of Chk1 and inhibit Chk1 phosphorylation of a cdc25C peptide with an IC 50 of 5 nM. AZD7762 abrogated checkpoint cell cycle arrest mediated by DNA-Damaging agents. AZD7762 was shown to abrogate the G 2 arrest induced by camptothecin with an average EC 50 of 10 nM and maximal abrogation in the range of 100 nM. AZD7762 treatment enhanced the radiosensitivity of p53-mutated tumor cell lines to a greater extent than for p53 wild-type tumor lines. AZD7762 treatment abrogated radiation-induced G(2) delay, inhibited radiation damage repair (assessed by gamma-H2AX), and suppressed radiation-induced cyclin B expression.
Download
Download Datasheet